Anti-Human Claudin-18 Reference Antibody (Tecotabart, RUO)
Anti-Human Claudin-18 Reference Antibody (Tecotabart, RUO) 

Anti-Human Claudin-18 Reference Antibody (Tecotabart, RUO)

  • Catalog number: BS12392
  • Availability: In Stock
  • $370.00

  • Ex Tax: $370.00


Available Options

Qty
Description: Tecotabart (BS12392) is a research-grade recombinant antibody targeting Claudin-18. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Humanized
Isotype: IgG1-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: Claudin-18,CLDN18
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: CAS:2823329-10-6
Background: Claudin-18 (CLDN18) is a ~27 kDa protein. Involved in alveolar fluid homeostasis via regulation of alveolar epithelial tight junction composition and therefore ion transport and solute permeability, potentially via downstream regulation of the actin cytoskeleton organization and beta-2-adrenergic signaling. Required for lung alveolarization and maintenance of the paracellular alveolar epithelial barrier. Acts to maintain epithelial progenitor cell proliferation and organ size, via regulation of YAP1 localization away from the nucleus and thereby restriction of YAP1 target gene transcription. Acts as a negative regulator of RANKL-induced osteoclast differentiation, potentially via relocation of TJP2/ZO-2 away from the nucleus, subsequently involved in bone resorption in response to calcium deficiency. Mediates the osteoprotective effects of estrogen, potentially via acting downstream of estrogen signaling independently of RANKL signaling pathways.
Note: For research use only. Not suitable for clinical or therapeutic use.

Images

  • SDS-PAGE for Anti-Human Claudin-18 Reference Antibody (Tecotabart, RUO)
    SDS-PAGE

    SDS-PAGE for Research Grade Tecotabart.

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good